Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

CD56(bright) NK cell count predicts response to daclizumab in relapsing-remitting MS

Oct. 28, 2010

Combination of BG-12 with IFN-beta 1a or glatiramer acetate is safe in healthy subjects

Oct. 27, 2010

BMS-690514 shows potential to treat non-small cell lung cancer

Oct. 27, 2010

GM-CSF adjuvant enhances efficacy of AIDS vaccine in rhesus macaques

Oct. 27, 2010

Long-term data disclosed on alemtuzumab for treatment of relapsing-remitting MS

Oct. 27, 2010

Briakinumab is superior to methotrexate and etanercept in treating psoriasis

Oct. 27, 2010

HIV vaccine MV1-F4 induces robust immune response in monkeys

Oct. 26, 2010

Merck & Co. and Scynexis characterize new efumafungin antifungals

Oct. 26, 2010

Linifanib monotherapy is active in phase II NSCLC trial

Oct. 26, 2010

LNPEP gene SNP is associated with outcome of patients with septic shock

Oct. 26, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...